Murbraech, Klaus <br/><br/>
Cardiac response to early conversion from calcineurin inhibitor to everolimus in renal transplant recipients--a three-yr serial echocardiographic substudy of the randomized controlled CENTRAL trial.  [electronic resource] 

 -  Clinical transplantation  Aug 2015 
 - 678-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1399-0012 
<br/><br/><label>Standard No.: </label>10.1111/ctr.12565  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Blood Pressure Determination<br/>Calcineurin Inhibitors--therapeutic use<br/>Diastole--drug effects<br/>Echocardiography<br/>Everolimus--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Glomerular Filtration Rate<br/>Graft Survival<br/>Heart--drug effects<br/>Heart Diseases--prevention & control<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Failure, Chronic--surgery<br/>Kidney Function Tests<br/>Kidney Transplantation<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Risk Factors<br/>Systole--drug effects<br/>Transplant Recipients